Handwriting characteristics in patients with overt autoimmune hypothyroidism: a prospective case-control study.
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
16
02
2020
accepted:
23
03
2020
pubmed:
8
4
2020
medline:
22
6
2021
entrez:
8
4
2020
Statut:
ppublish
Résumé
Previous studies have demonstrated handwriting changes in patients with overt hyperthyroidism due to Graves' disease. The aim of the present study was to investigate handwriting features in patients affected by overt autoimmune hypothyroidism. Thirty subjects - 24 females and 6 males, mean and median age of 50.15 ± 16.8 years and 52.5 years, respectively - with overt hypothyroidism (OH) related to Hashimoto's thyroiditis (Group 1), and 30 age- and sex-matched euthyroid individuals (Group 2) were recruited to write a "standard text". Group 1 patients repeated the text once the euthyroid state was reached on L-T4 substitution therapy. Group 2 subjects wrote the text again 1 to 4 weeks thereafter. The letters underwent a detailed analysis by a handwriting expert, through inspection, a stereoscopic microscope and a magnifying glass. Furthermore, the time that both Groups took to go through with the text was clocked. None of the handwriting variables differed significantly within each Group and between the two Groups. Hypothyroid patients took significantly more time to go through with the text compared to the time taken once they became euthyroid (3.29 ± 1.66 vs 2.63 ± 1.55 minutes, respectively) and the time taken by the control group (p < 0.01). Of note, three Group 1 patients missed to copy some words or even whole sentences on the paper while they were overtly hypothyroid. The present study demonstrates that handwriting speed is able to disclose the impact of thyroid hormone deficiency on the central nervous system's functions. In particular, the longer time taken to go through with the text and the sentences missed by some hypothyroid patients, are the counterpart of psychomotor slowdown, impaired attention and memory loss peculiar to OH.
Identifiants
pubmed: 32253679
doi: 10.1007/s12020-020-02282-9
pii: 10.1007/s12020-020-02282-9
doi:
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
651-654Références
L. Chaker, A.C. Bianco, J. Jonklaas, R.P. Peeters, Hypothyroidism. Lancet 390, 1550–1562 (2017)
doi: 10.1016/S0140-6736(17)30703-1
W.M. Wiersinga, Myxedema and coma (severe hypothyroidism). in L.J. De Groot, G. Chrousos, K. Dungan, et al., eds (Endotext. South Dartmouth, MA, MD Text.com, 2000)
J. Jonklaas., A.C. Bianco, A.J. Bauer, et al. On behalf of American Thyroid Association Task Force on thyroid hormone replacement: Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid 24, 1670–1751 (2014)
doi: 10.1089/thy.2014.0028
G. Papi, C. Botti, S.M. Corsello, A.V. Ciardullo, A. Pontecorvi, L. Hegedüs, The impact of Graves’ disease and its treatment on handwriting characteristics. Thyroid 24, 1218–1222 (2014)
doi: 10.1089/thy.2013.0668
Y.G. Kim, Structural relations of language and cognitive skills, and topic knowledge to written composition: a test of the direct and indirect effects model of writing. Br. J. Educ. Psychol. (2019). https://doi.org/10.1111/bjep.12330
K. Bavarsad, M. Hosseini, M.A. Hadjzadeh, A.Sahebkar, The effects of thyroid hormones on memory impairment and Alzheimer’s disease. J. Cell. Physiol. (2019). https://doi.org/10.1002/jcp.28198
A. Accorroni, G. Chiellini, N. Origlia, Effects of thyroid hormones and their metabolites on learning and memory in normal and pathological conditions. Curr. Drug. Metab. 18, 225–236 (2017)
doi: 10.2174/1389200218666170116112407
J. Bernal, Thyroid hormone receptors in brain development and function. Nat. Clin. Pract. Endocrinol. Metab. 3, 249–259 (2007)
doi: 10.1038/ncpendmet0424
J.M. Dubuis, J. Glorieux, F. Richer, C.L. Deal, J.H. Dussault, G. Van Vliet, Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment. J. Clin. Endocrinol. Metab. 81, 222–227 (1996)
pubmed: 8550756